Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lung Neoplasms 5Radiation Injuries 2Head and Neck Neoplasms 2Glioblastoma 2Esophageal Neoplasms 2Cardiotoxicity 2Vaginal Neoplasms 1Urinary Bladder Neoplasms 1Tobacco Use Disorder 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Smoking 1Rectal Neoplasms 1Ototoxicity 1Neoplasms 1Nasopharyngeal Carcinoma 1Lymphatic Metastasis 1Locally Advanced Cervical Cancer 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Heart Diseases 1Hearing Loss 1Cognitive Dysfunction 1Cholangiocarcinoma 1Cardiovascular Diseases 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Adult Patients With Locally Advanced Rectal Cancer Indicated to Neoadjuvant Therapy and Surgery 1

Interventions

Surveys and Questionnaires 9Cystectomy 6Blood Specimen Collection 5Neoadjuvant Therapy 4Cystoscopy 4Drug Therapy 3avelumab 2Urination 2Urinary Diversion 2Surgical Procedures, Operative 2Radiotherapy 2Pioglitazone 2Microarray Analysis 2Methods 2Magnetic Resonance Spectroscopy 2Interviews as Topic 2Immunohistochemistry 2Defecation 2Biopsy 25-aminolevulinic acid hexyl ester 2trastuzumab deruxtecan 1sargramostim 1pembrolizumab 1erdafitinib 1enfortumab vedotin 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Watchful Waiting 1Urinary Sediment Analysis 1Therapeutics 1Specimen Handling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Urinary Bladder Neoplasms × Chemoradiotherapy × Clear all
NCT04812145 2021-03-23

Role of Hypofractionated Radiotherapy With Concurrent Gemcitabine in Treatment of Urinary Bladder Carcinoma

Assiut University

Unknown
50 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡